August 23, 2022
1 min read
Save
Vascular closure system utilizing plant-derived hemostatic foam gains FDA clearance
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOAG LLC, a Minneapolis-based medical device firm, announced it received FDA clearance for its topical vascular closure system.
The system (Vascette HP) is a topical closure pad incorporating a plant-derived hemostatic foam to support rapid hemostasis following cardiac catheterization without direct compression over the arterial puncture site, according to a press release issued by the company.
The company stated it will exhibit the topical closure pad at the Association for Vascular Access congress in Minneapolis, Sept. 30 through Oct 2, 2022.
Published by:
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.